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Abstract
Background: In the fusion pathway of trophoblast differentiation, stem villous cytotrophoblast
cells proliferate and daughter cells differentiate and fuse with existing syncytiotrophoblast to
maintain the multi-nucleated layer. Integrin-linked kinase (ILK) is highly expressed in 1st and 2nd
trimester villous cytotrophoblast cells, yet barely detectable in syncytiotrophoblast, thus we
examined the potential role of ILK in aiding trophoblast fusion.
Methods: The temporal/spatial expression and activity of ILK were determined in BeWo cells
undergoing syncytialization by immunoblot and immunofluorescence analyses. BeWo cells were
also transfected with pEGFP expression vectors containing wildtype or two mutant ILK cDNA
constructs. The incidence of cell fusion in transfected cells grown under syncytialization conditions
was then scored by the presence or absence of E-cadherin immunostaining. Beta-hCG expression
in transfected cells, a marker of syncytiotrophoblast hormonal differentiation, was also similarly
assessed.
Results: ILK catalytic activity increased and ILK began to increasingly localize to BeWo cell nuclei
during syncytialization in correlation with increased pAkt and Snail protein expression.
Syncytialization was also significantly elevated (p < 0.05) in BeWo cells expressing constitutively
active (ca)-ILK vs cells containing empty vector or dn-ILK. Furthermore, cytoplasmic Beta-hCG
expression markedly increased (p < 0.05) in cells expressing wt- and ca-ILK.
Conclusion: ILK-facilitated syncytialization is dependent, at least in part, on ILK catalytic activity
while hormonal differentiation appears dependent on both ILK-associated protein interactions and
catalytic activity. This study demonstrates that ILK plays a novel role in BeWo syncytialization and
differentiation, perhaps through an ILK-Akt-Snail pathway, and implicates ILK in the same process
in villous cytotrophoblasts in vivo.
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Background
The human placenta is a critical organ formed during
pregnancy that possesses an array of specialized meta-
bolic, hormonal, and immunological functions that con-
trol the growth and viability of the fetus and, in turn, the
health of the mother [1-4]. The importance of proper pla-
cental development to the health and well being of the
fetus and mother is illustrated in conditions that arise dur-
ing pregnancy such as preeclampsia, gestational diabetes
and intrauterine growth restriction, that are thought to be
the result of placental abnormalities [5].
In the human fetal placenta, the floating villi represent the
majority of the chorionic villi and are bathed in maternal
blood to function in hormone transport and to aid in the
exchange of gases, nutrients and waste between the mother
and fetus [2,5]. The floating villi consist of an outer multi-
nucleated syncytiotrophoblast layer, an underlying mitoti-
cally active mononuclear cytotrophoblast layer and a
stroma [4]. In the cytotrophoblast layer, polarized stem
cytotrophoblast cells proliferate and daughter cells then
differentiate and fuse with existing syncytiotrophoblast to
maintain the multi-nucleated layer [reviewed by [6]]. Mor-
phometric analyses have indicated that in the first trimester
there is an excess of villous cytotrophoblast cells fusing
with the syncytiotrophoblast – likely necessary for the met-
abolic integrity of the syncytiotrophoblast [7], although
Ellery et al [8] has recently demonstrated that a proportion
of nuclei in the syncytiotrophoblast are actively engaged in
transcription in accordance with the high metabolic and
secretory activity of the tissue. While proliferation of villous
cytotrophoblast cells falls with advancing gestation, the
cytotrophoblast layer is not entirely discontinuous. Mori et
al [9] and Jones et al [10] have calculated ~45–80% conti-
nuity of the cell layer at term with cytotrophoblast cells
being transformed into flat cells with many thin cellular
interdigitating processes. While the events leading to main-
tenance of the cytotrophoblast stem cell population as well
as cytotrophoblast differentiation and fusion are poorly
understood, it is becoming clear that initiation of an apop-
tosis cascade occurs early in differentiation [11,12]. A flip
of phosphatidylserine within the cytotrophoblast cell
membrane is also associated with cytotrophoblast fusion
[7,13]. Since the villous cytotrophoblast and syncytiotro-
phoblast comprise the epithelial covering of the chorionic
villi that is in contact with maternal blood, any distur-
bances in the processes of cytotrophoblast proliferation
and fusion of cytotrophoblast with overlying syncytiotro-
phoblast can seriously perturb the turnover and function of
the syncytiotrophoblast layer and ultimately may contrib-
ute to development of fetal growth restriction or preec-
lampsia [14].
Research has demonstrated that syncytin-1, a retroviral
envelope protein, appears to have a direct role in human
trophoblast fusion [15]. Furthermore, glial cells missing-1
(GCM1), a transcription factor, appears to be upregulated
in pre-fusing cytotrophoblast and to regulate syncytin-1
mRNA expression [15-17]. Along with these findings,
other proteins or groups of proteins such as protein tyro-
sine kinases and protein tyrosine phosphatases with a
variety of other known functions also appear to play
important roles in the fusion pathway [18,19]. An intrac-
ellular serine/threonine kinase named Integrin-linked
kinase (ILK) localizes to focal adhesions and is critically
involved in the adhesion of cells to their extracelluar envi-
ronment and in signal transduction [20,21]. ILK interacts
with the cytoplasmic domains of β-integrins and numer-
ous cytoskeletal associated proteins and has been found
to mediate protein-protein interactions.
Recently, Elustondo et al [22] reported that ILK was highly
detectable by immunoblot analyses in human chorionic
villous tissue lysates throughout gestation. It was also
highly expressed in situ in villous cytotrophoblast cells and
in stromal mesenchyme in first trimester and early second
trimester human chorionic floating villi; however, it was
scarcely detected in the syncytiotrophoblast layer. The
adherens junction protein E-cadherin mediates
homophilic calcium- dependent cell adhesion in neigh-
bouring cells and is also highly detectable at points of
cytotrophoblast cell-cell contact [23,24]. E-cadherin
expression markedly decreases with remodeling of cell-cell
adhesion complexes associated with differentiation and
subsequent fusion of cytotrophoblast to syncytiotrophob-
last [24] and, thus, presence/absence of the protein can be
used to assess trophoblast syncytialization [25-27]. As yet,
the mechanism(s) underlying the downregulation of E-cad-
herin expression in villous cytotrophoblast undergoing the
morphogenetic process of syncytialization is unknown.
Hannigan et al [28] has demonstrated that over-expres-
sion of ILK in epithelial cells results in disrupted cell-cell
adhesion. ILK also downregulates E-cadherin expression
through activation of the transcriptional repressor Snail,
independent of β-catenin/T cell factor (TCF7) regulation
[29]. Based on the reported role of ILK in regulating E-cad-
herin expression and the known expression of both ILK
and E-cadherin expression in the cytotrophoblast of
human chorionic villi during pregnancy, we hypothesized
that ILK could be a player in regulating the differentiation
and fusion of cytotrophoblast into the syncytiotrophob-
last via the downregulation of E-cadherin. To begin testing
this hypothesis we employed a well documented cell line
model, BeWo cytotrophoblast cells, for the study of tro-
phoblast syncytialization [30,31].
Methods
Cell culture
The BeWo cell line was purchased from the American Type
Culture Collection (Cat. #CCL-98, Manassas, VA, USA).
This cell line was originally derived from a human tro-Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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phoblast choriocarcinoma and is well known to undergo
syncytialization upon forskolin treatment [32]. This cell
line model is ideal for experiments because syncytializa-
tion can be controlled with syncytialization of up to 80%
[33]. They can be grown under proliferating conditions
indefinitely where they exhibit an epithelial phenotype or
under syncytialization conditions where it is well known
that BeWo cells express markers of syncytiotrophoblast
such as β-hCG, syncytin, and markedly decreased E-cad-
herin and desmoplakin expression [15,24,33-36].
Cells were cultivated in 75 cm2 culture flasks in Ham's F-12
media with L-glutamine (Cat. #11765-062; Invitrogen Ltd.,
Burlington, Ontario, Canada) supplemented with 10%
fetal bovine serum (Cat. #16000-044; Invitrogen) and 100
U penicillin/100 μg (Cat. #15140-122; Invitrogen) as has
been described elsewhere [37]. The BeWo cells were main-
tained under standard culture conditions of 5% carbon
dioxide in air at 37°C with medium renewal on a daily
basis. This tissue culture media formulation and associated
culture parameters were designated "proliferating condi-
tions". Once cells reached ~80% confluency they were pas-
saged into new tissue culture flasks with new media at a
ratio of 1:4. For culture of BeWo cells to promote syncytial-
ization the same conditions as above were utilized except
that the media was simply changed to Ham's F-12K media
(Cat. # 21127-022) containing 25 μM Forskolin (Cat.
#F6886; Sigma Chemical Co, St. Louis, Missouri, USA).
This media formulation and culture parameters were desig-
nated as "syncytialization conditions".
BeWo transfection and determination of syncytialization 
and β-hCG expression
BeWo cells were counted with a haemocytometer and the
concentration was adjusted to 2.5 × 105 cells/ml. Cells
were initially seeded on either 22 × 22 cm glass coverslips,
seated in 35 mm tissue culture dishes, or in 6 well plates
and cultivated in proliferating conditions as described
above. When the cells reached approximately 80% conflu-
ence they were washed with media without FBS or antibi-
otics and transiently transfected with 2.0 μg of empty
pEGFP-C3 vector (Cat. #6082-1; BD Clontech), pEGFP-
C3 containing human wild-type (wt)-ILK, pEGFP-C3 con-
taining dominant-negative human E395K (dn)-ILK, or
pEGFP-C3 containing a constitutively active human
S343D (ca)-ILK construct and 8.0 μl of Lipofectamine
2000 (Cat. #11668-027; Invitrogen). Transfections were
conducted according to the manufacturer's detailed
instructions. Six hours after transfection the cells were cul-
tivated in syncytialization conditions and the media
replenished 24 hours after transfection.
The incidence of syncytialization in transfected cells was
scored by the presence or absence of E-cadherin immu-
nostaining in twenty microscopic high power fields of
view (400× observed magnification). The use of E-cad-
herin immunostaining has been utilized in the past for
such assessments of trophoblast fusion [25-27]. Syncytial-
ization was considered genuine when at least 3 or more
nuclei were present in the same cytoplasm. The incidence
of β-hCG expression in transfected cells was also scored by
the presence or absence of β-hCG immunostaining in
twenty microscopic high power fields of view (400×
observed magnification).
Immunocytochemical analysis
BeWo cell syncytialization time course
BeWo cells were initially seeded on 22 × 22 mm glass cov-
erslips (2.5 × 105 cells/coverslip) seated in 35 mm culture
dishes and grown in proliferating conditions for 24 hours.
Cells were then fixed in 4% paraformaldehyde/PBS for 15
minutes under these proliferating conditions (0 h) or sub-
sequently at 3, 6, 9, 12, 18, 24, 36, or 48 h after initiation
of culture in syncytialization conditions. Cells were then
washed once with 1 × PBS for 5 minutes.
ILK fusion protein overexpression
For immunolocalization of E-cadherin or β-hCG in EGFP-
fusion protein expressing cells, forty eight hours after
transfection BeWo cells were washed with 1 × PBS for 2 ×
5 minutes each. The cells were then fixed in 4% parafor-
madehyde/PBS for 15 minutes and then washed once
with 1 × PBS for 5 minutes.
For immunocytochemical analyses, all cells were placed
in PBS containing 0.1% Triton X-100 (PBT) for 15 min-
utes at room temperature and subsequently washed with
1 × PBS for 5 minutes. The cells were then blocked in 5%
normal goat serum/1% horse serum/1% fetal bovine
serum in PBS for 1 h at room temperature with constant
agitation, then incubated for 1 hour at room temperature
in appropriate primary antisera (Table 1). Affinity-puri-
fied mouse and rabbit IgG, at the same concentration as
the primary antisera, served as negative controls for
immunocytochemical analyses. After three washes in PBT,
cells were incubated with appropriate secondary antisera
(Table 1). The cells were then washed two times with PBT
followed by a final wash in PBS. The cells were then
mounted in Vectashield containing DAPI (Cat # H-1200;
Vector Laboratories Inc., Burlington, Ontario, Canada).
All cells were observed using a Leica DM-IRE2 inverted
microscope (Leica Microsystems, Richmond Hill,
Ontario, Canada) equipped for epifluorescence illumina-
tion and attached to a Retiga Exi CCD camera (QImaging,
Burnaby, B.C, Canada). Openlab Image Analysis software
(Version 5.5; Improvision, Inc., Lexington, Massachusetts,
USA) was used for image capture and analysis.
Immunoblot analysis
BeWo cell syncytialization time course
BeWo cells were initially seeded at 2.5 × 105 cells/well in
35 mm culture dishes in Ham's F12 media and culturedReproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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for 24 hours. Cells were then lysed from these culture con-
ditions (0 h) or at 3, 6, 9, 12 18, 24, 36, or 48 h after ini-
tiation of culture in syncytialization conditions. 250 μl of
NP-40 lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1%
Nonidet P-40) containing 100 μM sodium orthovanadate
and complete Mini EDTA-free protease inhibitors (Roche
Molecular Biochemicals, Laval, Quebec, Canada) were
added to the cells. Cells were harvested with a plastic cell
scraper and homogenized with moderate pipetting. Sam-
ples were cleared by centrifugation and supernatants were
retained for immunoblot analysis.
ILK fusion protein overexpression
BeWo cells were initially seeded at 3.5 × 105 cells/well in
6 well plates and transiently transfected with either the
pEGFP -C3 vector or one of the pEGFP-C3 containing ILK
constructs described above. Cells were then cultivated in
syncytialization conditions at 6 and 24 hours post-trans-
fection as described above. Forty- eight hours after trans-
fection, 250 μl of NP-40 lysis buffer (50 mM Tris pH 8.0,
150 mM NaCl, 1% Nonidet P-40) containing 100 μM
sodium orthovanadate and complete Mini EDTA-free pro-
tease inhibitors (Cat. # 11836170001; Roche Molecular
Biochemicals, Laval, Quebec, Canada) were added to the
cells. Cells were harvested with a plastic cell scraper and
homogenized with moderate pipetting. Samples were
cleared by centrifugation and supernatants were retained
for immunoblot analysis.
For all immunoblot analyses, sample protein concentra-
tions were determined by the Bradford Assay using the
Bio-Rad protein assay dye reagent (Bio-Rad Laboratories,
Mississauga, Ontario, Canada). Protein samples (30 μg/
lane) were separated in 10% polyacrylamide gels under
denaturing conditions and gels were blotted to Pierce 0.45
μm nitrocellulose membranes (MJS Biolynx, Inc, ON,
Canada). Blots were washed with Tris buffered saline-
Tween-20 (TBST; 20 mM Tris base, 137 mM NaCl, and
0.1% Tween 20, pH 7.6) and blocked with 5% BSA/TBST
for 1 h. Appropriate antisera (Table 1) were incubated
with blots at 4°C overnight with constant agitation. The
next day, blots were washed with TBST and then incu-
bated in relevant horseradish peroxidase (HRP)-conju-
gated goat secondary antisera for 1 hour at room
temperature with constant agitation. Following washes in
TBST, proteins were detected on immunoblots using the
Pierce SuperSignal West Pico chemiluminescent substrate
detection system (Cat #34080; MJS Biolynx, Inc) and mul-
tiple exposures were generated to ensure the linearity of
the film responses.
β-hCG ELISA
BeWo cells were either grown under proliferating or syn-
cytialization conditions for 48 hours, with the media
being replenished once at 24 hours after initial seeding.
After 48 hours, the media was collected and the ELISA
conducted with a β-hCG ELISA kit (Cat # EIA-1469; DRG
Diagnostics, New Jersey, USA) exactly according to the
manufacturer's instructions.
Nonradioactive IP kinase assay
BeWo cells were seeded in 35 mm culture dishes at 2.5 ×
105 cells/well and cultured in either proliferating condi-
tions or syncytialization conditions as described above.
After 48 hours of culture, the cells were lysed with NP-40
lysis buffer containing 100 μM sodium orthovanadate
Table 1: Antisera utilized for immunofluorescence and immunoblot analysis.
Antisera Method Dilution Company Catalogue #
Mouse anti-ILK; Clone 65.1.9 IF 1:100 Abcam, Ltd, Cambridge, MA, USA ab49979
Rabbit anti-ILK IB 1:2000 Cell Signaling Technology, Beverly, MA, USA 3862
Rabbit anti-E-cadherin IF 1:250 Abcam, Ltd, Cambridge, MA, USA ab15148
Mouse anti-E-cadherin, clone SHE78-7 IF
IB
1:1000
1:10000
EMD Biosciences, San Diego, CA, USA 205602
Rabbit anti-hCG IF 1:500 Dako Canada, Inc, Mississauga, ON, Canada A0231
Rabbit anti-Snail IB 1:1000 Abcam, Ltd, Cambridge, MA, USA ab17732
Mouse anti-pAKT1 (Ser 473); Clone 587F11 IF 1:100 Cell Signaling Technology, Beverly, MA, USA 4051
Rabbit anti-pAKT1 (Ser 473) IB 1:1000 Cell Signaling Technology, Beverly, MA, USA 9271
Anti-phospho-GSK3β (Ser-9) IB 1:1000 Cell Signaling Technology, Beverly, MA, USA 9336
FITC-Sheep anti-Rabbit IgG IF 1:250 Sigma Chemical Co, St. Louis, MO, USA F7512
RRX-Donkey anti-Mouse IgG IF 1:150 Jackson ImmunoResearch Labs Inc, West Grove, USA 715-295-150
RRX-Donkey anti-Rabbit IgG IF 1:250 Jackson ImmunoResearch Labs Inc, West Grove, USA 711-295-152
ChromPure Mouse IgG IF N/A* Jackson ImmunoResearch Labs Inc, West Grove, USA 015-000-003
ChromPure Rabbit IgG IF N/A* Jackson ImmunoResearch Labs Inc, West Grove, USA 011-000-003
HRP-Goat anti-Rabbit IgG (H+L) IB 1:20000 Pierce, Rockford, IL, USA 31460
HRP-Goat anti-Mouse IgG (H+L) IB 1:10000 Pierce, Rockford, IL, USA 31430
IF: immunofluorescence, IB: immunoblot, FITC: Fluorescein isothiocyanate, RRX: Rhodamine-Red-X, HRP: horseradish peroxidase, *Dependent on 
concentration of primary antisera utilizedReproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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and complete Mini EDTA-free protease inhibitors and
protein concentrations determined as described previ-
ously. For immunoprecipitation, 4.0 μg of mouse mono-
clonal ILK antisera or non-specific IgG (see Table 1) was
added to 400 μg of appropriate BeWo cell lysate and incu-
bated overnight at 4°C with gentle agitation. Fifty micro-
litres of TrueBlot anti-mouse IP beads (Cat # 00-8811;
eBiosciences, San Diego, California, USA) were added to
each sample and incubated for 2 hours at 4°C with gentle
rocking. Then ILK-antibody-bead complexes were centri-
fuged at 13,000 × g for 1 minute at 4°C and subsequently
washed 3 × with 500 μl of NP- 40 lysis buffer followed by
3 washes with 500 μl of kinase buffer (Cat # 9802; Cell
Signaling). Complexes were then each suspended in 50 μl
of kinase buffer supplemented with 1.0 μl of 10 mM ATP
(Cat # 9804; Cell Signaling) and 1 μg of GSK-3β fusion
protein (Cat # 9237; Cell Signaling) and incubated for 30
minutes at 30°C. The reaction was then terminated with
12.0 μl of 5× SDS polyacrylamide gel loading buffer fol-
lowed by vortexing and centrifugation for 30 seconds at
14,000 × g. All samples were heated to 95°C for 5 minutes
prior to loading on 10% polyacrylamide gels and SDS-
PAGE followed by electroblotting to Pierce 0.45 μm pore
nitrocellulose membrane (MJS Biolynx, Inc). Immunob-
lot analyses of phosphorylated GSK-3β (Ser-9) and ILK
proteins were then conducted.
Data analysis
Statistical analysis was performed with GraphPad Prism®
version 5.01 (GraphPad Software, San Diego, California,
USA). Statistical significance for the determination of the
incidence of cell fusion and intracellular β-hCG expres-
sion were analyzed with a one-way analysis of variance
(ANOVA) and a Newman-Keuls multiple comparisons
test. Values were considered significantly different if p <
0.05. Densitometric analyses of immunoblot data was
conducted with a one-way ANOVA followed by pair wise
comparison of data points with two tailed unpaired t-
tests.
Results
ILK expression during BeWo syncytialization
ILK protein was readily detectable in BeWo cell lysates
from cells cultured under proliferating conditions (Fig.
1A; 0 h). Upon culture in syncytialization-promoting con-
ditions of Ham's F12K + 25 um Forskolin, ILK expression
consistently decreased by 6 h of culture and was signifi-
cantly lower by 12 h vs 0 h (p < 0.05). Expression quickly
recovered and reached detection levels at 48 h of culture
that were comparable to ILK expression at 0 h. In contrast,
ILK kinase activity, measured by phosphorylation of a
GSK3β fusion protein, was markedly higher at 48 h of cul-
ture in syncytialization-promoting conditions compared
to activity in cells cultivated in proliferating conditions
(Fig. 1B). This result was also concomitant with increased
syncytin protein expression and β-hCG secretion occur-
ring in syncytializing BeWo cells, as has been previously
described [35,36], compared to cells cultivated under pro-
liferating conditions (Fig. 1C, D). These results thus indi-
cate that ILK protein expression and activity are
dynamically regulated during BeWo syncytialization.
The spatial localization of ILK also changed dynamically
during BeWo syncytialization (Fig. 2). Under proliferating
culture conditions (0 h), ILK was localized in the cell cyto-
plasm, at focal adhesion-like structures and particularly
present at cell-cell adhesions marked by E-cadherin
expression (Fig. 2, arrows; inset). Once BeWo cells were
cultured under syncytialization conditions, ILK localiza-
tion shifted over the timecourse of culture to an increased
nuclear localization concomitant with decreasing E-cad-
herin detection in cell-cell adhesions (Fig. 2). However,
ILK could still be detected at decreased levels in the cyto-
plasm at 12 h and then in the cytoplasm and to focal-
adhesion like structures at the cell periphery from 24–48
h (Fig. 2). Since BeWo cells grown under syncytialization
conditions can achieve up to 80% syncytialization [33],
some BeWo cell clusters do not syncytialize. Interestingly,
in these cases we consistently observed that where syncy-
tialization was not evident, as marked by sustained and
readily detectable E-cadherin in cell-cell adhesions, ILK
localization to cell nuclei was markedly decreased (Fig. 3;
24 h vs 12 h panels).
Consequences of ILK fusion protein expression in BeWo 
cells
BeWo cells were transfected under proliferating condi-
tions with pEGFP-C3 expression vectors containing
wildtype or mutant ILK cDNAs. Cells were then grown
under fusion promoting conditions to assess the impacts
of the expression of various EGFP-ILK proteins on tro-
phoblast fusion. Transient expression of EGFP-wt-ILK,
EGFP-dn-ILK, and EGFP-ca-ILK for 48 h in BeWo cells
under fusion conditions resulted in significant detection
of these proteins on immunoblots at the expected ~80
kDa, in addition to endogenous levels of ILK (Fig. 4).
These results confirmed the viability of these vectors and
also demonstrated that the expression of the various
EGFP-ILK proteins were comparable between the respec-
tive transfectants for our studies. The expression of all the
EGFP-fusion proteins was also readily observable by
immunofluorescence.
During culture of BeWo cells under both proliferating and
syncytialization conditions, cells were routinely moni-
tored by phase contrast microscopy to qualitatively assess
the condition of the cell cultures. To determine the inci-
dence of syncytialization in transfected cells, the presence
(no syncytialization) or absence (syncytialization) of E-
cadherin in cell membranes of EGFP-fusion proteinReproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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ILK protein expression and catalytic activity during BeWo syncytialization Figure 1
ILK protein expression and catalytic activity during BeWo syncytialization. A) Immunoblot analyses of ILK protein 
expression during a timecourse (0 h – 48 h) of BeWo syncytialization. A representative immunoblot is shown from four inde-
pendent experiments (n = 4). Middle panel is a representative immunoblot stained for total protein demonstrating comparable 
protein loading between gel lanes. 37 kDa – 75 kDa represent the position of molecular weight markers. The graph demon-
strates the densitometric analysis of ILK protein expression during the timecourse (n = 4). * p < 0.05 vs 0 h and 48 h; **p < 
0.05 vs 0 h. B) Representative immunoblots from in vitro kinase assays (n = 4) of ILK catalytic activity in BeWo cells grown 
under proliferating or syncytialization conditions (Syncytial.). Syncytial. -IgG only = immunoprecipitations with non-specific IgG 
in place of the primary ILK antisera. P-Ser-9-GSK3β = phosphorylated GST-GSK3β fusion protein. GST-GSK3β = total fusion 
protein used in the assay. C) A representative immunoblot demonstrating increased syncytin protein expression after 48 h of 
BeWo cell culture in syncytialization conditions (Syncytial.) compared to proliferating conditions (0 h). D) A representative 
ELISA demonstrating increased β-hCG secretion from BeWo cells after 48 h of culture in syncytialization conditions (Fused 
BeWo) compared to cell culture under proliferating (Non-fused BeWo) conditions (n = 8).Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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expressing cells was assayed by immunofluorescence anal-
ysis (Fig. 5). Transient expression of dn-ILK in BeWo cells
resulted in a slight decrease in trophoblast cell fusion,
compared to vector control transfected cells, but the
decreased levels did not reach statistical significance (Fig.
5; Table 2). In contrast, expression of wt-ILK caused a sig-
nificant increase in cell fusion, compared to dn-ILK
expressing cells (p < 0.05), and expression of ca-ILK in
BeWo cells significantly increased cell fusion (P < 0.05)
compared to dn-ILK and empty vector expressing cells
(Fig. 5; Table 2).
Upon stimulation of BeWo cells with forskolin, it is well
known that β-hCG expression and secretion are upregu-
lated [35], thus serving as a marker of trophoblast hormo-
nal differentiation. ELISA analyses of β-hCG secretion
into culture media from transiently transfected BeWo cells
demonstrated that any differences in β-hCG secretion
could not be statistically distinguished between the differ-
ent transfected cells (data not shown) likely due to the
background of β-hCG secretion from non-transfected
BeWo cells. Thus, using immunofluorescence analysis we
specifically examined the cytoplasmic expression of β-
hCG in transfected BeWo cells (Fig. 6). BeWo cells trans-
fected with empty vector did express some β-hCG in the
cytoplasm but dn-ILK expressing cells showed dramati-
cally reduced (p < 0.05) β-hCG expression (Fig. 6; Table
3). In contrast, wt-ILK and ca-ILK expressing cells showed
markedly enhanced expression (p < 0.05) of β-hCG in the
cell cytoplasm compared to dn-ILK and vector control
cells (Fig. 6; Table 3).
Expression of candidate ILK partners in BeWo 
syncytialization
To begin identifying candidate molecules that could part-
ner with ILK to promote syncytialization, we examined a
timecourse of BeWo cell syncytialization by immunoblot
analysis. Phosphorylated (Ser 473)-Akt expression, a sub-
strate of ILK activity, consistently increased by 48 h of
BeWo culture under syncytialization-promoting condi-
Immunofluorescence analyses for E-cadherin (left panels) and  ILK (right panels) protein expression in BeWo cells during a  timecourse of syncytialization Figure 2
Immunofluorescence analyses for E-cadherin (left 
panels) and ILK (right panels) protein expression in 
BeWo cells during a timecourse of syncytialization. 
Cells were cultivated under proliferating conditions (0 h) or 
syncytialization conditions (12 h – 48 h). With increasing cul-
ture time in syncytialization conditions, ILK began to localize 
to cell nuclei in addition to the cytoplasm and to focal adhe-
sions (arrowheads, 24 h – 48 h). Arrows in 0 h panels show 
the position of apparent ILK and E-cadherin co-localization 
demonstrated in the insets. IgG insets, non-specific IgGs of 
the appropriate animal species were used as specificity con-
trols in place of the appropriate primary antisera. Nuclei in E-
cadherin immunofluorescence panels were stained with 
DAPI. Scale bars = 25 μm.
Immunofluorescence analyses for E-cadherin (left panels) and  ILK (right panels) protein expression in BeWo cells at 12 h  and 24 h of cell culture in syncytialization conditions Figure 3
Immunofluorescence analyses for E-cadherin (left 
panels) and ILK (right panels) protein expression in 
BeWo cells at 12 h and 24 h of cell culture in syncy-
tialization conditions. The images demonstrate that ILK 
localization to cell nuclei correlates with downregulation of 
E-cadherin expression at cell-cell membranes. IgG insets, 
non-specific immunoglobulins of the appropriate animal spe-
cies were used as specificity controls in place of the appro-
priate primary antisera. Nuclei in E-cadherin 
immunofluorescence panels were stained with DAPI. Scale 
bars = 25 μm.Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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tions (Fig. 7A, B; 0 h vs 48 h, p < 0.05), in support of our
data from in vitro kinase assays of ILK activity at 48 h of
culture (Fig 1B). Furthermore, the expression of the tran-
scriptional repressor Snail was relatively low at 0 h until
after 12 h of culture in syncytialization conditions then
also became highly expressed by 48 h compared to 0 h
(Fig. 7A, C; p < 0.05). Thus, increased ILK activity appears
to correlate with increased Snail expression during syncy-
tialization and decreased detection of E-cadherin at cell-
cell adhesions (Figs. 1, 2, 7).
Discussion
Despite well known roles for ILK in cell-ECM adhesion
and signal transduction [20,21], ILK also appears to be
involved in integrin-independent epithelial cell-cell adhe-
sion [38,39]. We have previously reported that ILK was
highly expressed in villous cytotrophoblast cells in first
trimester and early second trimester human chorionic
floating villi, but that it was barely detected in the syncyti-
otrophoblast layer [22]. The adherens junction protein E-
cadherin is also highly detectable in human cytotrophob-
last and loss of E-cadherin in cytotrophoblast is associated
with syncytialization [24-27]. Importantly, ILK appears to
regulate E-cadherin expression [28,29]. Thus, using the
BeWo trophoblast cell line model we examined ILK
expression in BeWo cells during syncytialization and
tested the hypothesis that ILK could facilitate the differen-
tiation and fusion of cytotrophoblast into the syncytiotro-
phoblast.
Temporal and spatial expression of ILK is dynamically 
altered during syncytialization
Examination of ILK kinase activity during syncytialization
revealed that ILK activity is increased during syncytializa-
tion. This could lead to increased ILK-Akt signaling as Akt
is a substrate of ILK. While total ILK expression was signif-
icantly lower by 12 h (vs 0 h) of culture in syncytialization
conditions, expression quickly recovered and reached
detection levels at 48 h of culture that were comparable to
ILK expression at 0 h. However, more dramatic changes in
spatial expression of ILK were apparent during syncytiali-
zation as ILK began accumulating in cell nuclei. Recent
work by Acconcia et al [40] demonstrated that ILK can
localize to both cell cytoplasm and cell nuclei and that ILK
contains both functional nuclear localization and nuclear
export sequences. Furthermore, in MCF7 and NIH 3T3
cells ILK nuclear localization appears important for
nuclear integrity and ILK can associate with chromatin.
Since changes in ILK expression and catalytic activity were
associated with BeWo syncytialization, we examined
whether or not exogenous ILK overexpression in BeWo
cells could facilitate the process.
ILK facilitates BeWo syncytialization
The examination of the presence or absence of desmo-
somal or adherens junction (E-cadherin) proteins has
been successfully used for evaluating the incidence of
fusion in trophoblast [18,24,26,41,42]. Thus, we also
scored the incidence of syncytium formation in BeWo
cells overexpressing EGFP-ILK fusion proteins by examin-
ing the presence or absence of E-cadherin immunolocali-
zation. Transient expression of wt-ILK in BeWo cells
significantly increased trophoblast syncytialization com-
pared to dn-ILK while ca-ILK expression significantly
increased syncytialization compared to vector control and
dn-ILK expressing BeWo cells. The ILK constructs used for
our experiments have been utilized by other laboratories,
including ours, in a number of cell types [20,21]. We have
previously demonstrated that transient expression of dn-
ILK in the extravillous trophoblast cell line model HTR8-
SVneo significantly reduced trophoblast migration com-
pared to cells expressing wt-ILK [22]. The over-expression
of wt-ILK in a number of cell types can lead to phosphor-
ylation of Akt and GSK3-β while the active mutant ca-ILK
has been shown to constitutively phosphorylate Akt [43-
45]. The dominant negative mutant ILK was originally
considered a kinase dead mutant, but has since been
shown to have ~20% kinase activity in vitro [45-47] be
deficient in α-parvin and paxillin interaction, and to be
Immunoblot analysis of transient expression of wildtype (wt),  dominant negative (dn), and constitutively active (ca) EGFP- ILK fusion proteins in BeWo cells Figure 4
Immunoblot analysis of transient expression of 
wildtype (wt), dominant negative (dn), and constitu-
tively active (ca) EGFP-ILK fusion proteins in BeWo 
cells. A representative immunoblot demonstrating that the 
EGFP-ILK fusion proteins were readily detectable in BeWo 
cells 48 h post-transfection and absent in the empty vector 
transfected cells (pEGFP). Endogenous ILK (ILK) was detect-
able in all transfected and non-transfected cell lysates and 
total ERK2 detection served as an indication of comparable 
protein loading between lanes.Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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incapable of incorporating into focal adhesions thus
remaining only in the cytoplasm [48,49]. Therefore, it
appears to exert a strong dominant negative effect by
maintaining ILK associated proteins in an inappropriate
subcellular location (e.g. not focal adhesions) [49].
Since dn-ILK expressing BeWo cells only displayed a
slightly reduced level of syncytialization compared to vec-
tor control cells, it would appear that lack of focal adhe-
sion incorporation of ILK-associated proteins, but not
likely α-parvin or paxillin, does not significantly impact
BeWo syncytialization. Furthermore, the likelihood of
residual kinase activity from this mutant (not fully kinase
dead) may account for the less than significant reduction
in syncytialization in dn-ILK expressing BeWo cells. Tran-
sient expression of wt-ILK in BeWo cells did not signifi-
cantly increase trophoblast syncytialization compared to
vector control expressing cells. ILK activity is dependent
on PI-3 kinase activity in vivo [21] and, as a result, it is
possible that the overexpression of the wt-ILK fusion pro-
Immunocytochemical analysis of E-cadherin expression in BeWo cells transiently transfected with either pEGFP-C3 vector  (EGFP), pEGFP-C3 containing dominant negative ILK (EGFP-dnILK), wildtype ILK (EGFP-wt ILK) or constitutively active ILK  (EGFP-ca ILK) and cultivated under syncytialization conditions for 48 h Figure 5
Immunocytochemical analysis of E-cadherin expression in BeWo cells transiently transfected with either 
pEGFP-C3 vector (EGFP), pEGFP-C3 containing dominant negative ILK (EGFP-dnILK), wildtype ILK (EGFP-
wt ILK) or constitutively active ILK (EGFP-ca ILK) and cultivated under syncytialization conditions for 48 h. Ms 
IgG = mouse IgG negative control. Scale bar = 50 μm. Data are representative of three independent experiments.Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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tein may have saturated the endogenous PI-3 kinase
resulting in low activation levels of the exogenous wt-ILK
fusion protein. In contrast, our results with ca-ILK express-
ing BeWo cells indicate that ILK facilitates BeWo trophob-
last syncytialization and that it is likely dependent, at least
in part, on ILK catalytic activity. Fusion-promoting culture
conditions, particularly elevated cAMP levels and PKA
activation induced by forskolin addition [32,50], also
likely synergize with ILK catalytic activity to aid syncytial-
ization as ILK-induced syncytialization was absent in
BeWo cells grown only under proliferation-promoting
conditions (data not shown). In total, our results clearly
correlate with work by Miller et al [51] who demonstrated
that over-expression of ILK in L6 myoblasts resulted in
increased ILK activity and stimulation of myoblast fusion
into myotubes.
ILK induces intracellular β-hCG expression
The synthesis and secretion of β-hCG is a marker of syncy-
tiotrophoblast differentiation [6] and syncytializing
BeWo cells also express β-hCG mRNA and protein when
cultivated under fusion-promoting conditions [15,34,35].
In our experiments we examined β-hCG expression in
transfected cells using immunocytochemistry, as has been
previously done [34], since our transient transfection
strategy meant there was a background of β-hCG expres-
sion and secretion from untransfected cells. In vector con-
trol cells we detected some β-hCG expression as a result of
culture in fusion-promoting conditions; however, dn-ILK
expressing cells exhibited significantly lower levels of β-
hCG expression in situ compared to vector controls and
the other mutant ILK protein expressing cells. Thus, in
contrast to syncytialization, lack of proper subcellular
localization of ILK-associated proteins (dominant nega-
tive effect) does impact BeWo cell β-hCG expression and
differentiation. Furthermore, with the concern above
regarding proper catalytic activation of exogenous wt-ILK
in transfected BeWo cells, the significant increase in β-
hCG expression in these cells vs dn-ILK and vector con-
trols may also indicate a need for ILK, in addition to cata-
lytic activity, as an adapter protein and signaling platform
for other signalling proteins to aid proper hormonal dif-
ferentiation. What specific ILK-associated protein(s) may
be involved in hormonal differentiation of BeWo cells is
under investigation. The significant upregulation of β-
hCG expression in ca-ILK expressing BeWo cells highlights
that ILK catalytic activity, at least in part, also has a role in
promoting syncytiotrophoblast differentiation.
Candidate ILK signalling pathway
The underlying signaling mechanism that could be
responsible for ILK facilitated syncytialization of BeWo
Table 2: The incidence of BeWo syncytialization. The incidence of BeWo syncytialization was determined by scoring the absence of E-
cadherin immunolocalization in groups of EGFP-fusion protein expressing cells. Data are from three independent experiments.
Experiment BeWo + pEGFP-C3 BeWo + pEGFP-C3 -dn-ILK BeWo + pEGFP-C3 - wt-ILK BeWo + pEGFP-C3- ca-ILK
1 28/43 11/38 35/48 38/43
2 26/51 39/63 66/72 32/35
3 21/50 14/47 19/32 27/37
Avg. Incidence 
(% of 1.00 +/- SEM)
0.52 +/- 0.07 0.42 +/- 0.10 a0.73 +/- 0.09 b0.85 +/- 0.06
a: Syncytialization was significantly elevated in cells expressing wildtype (wt)-ILK versus dominant negative (dn)-ILK expressing cells (p < 0.05)
b: Syncytialization was significantly increased in BeWo cells expressing constitutively active (ca)-ILK vs cells containing pEGFP-C3 (empty vector) or 
dn-ILK (p < 0.05)
Table 3: The incidence of β-human chorionic gonadotropin (β-hCG) expression. The incidence of β-hCG expression was determined by 
the presence of β-hCG immunolocalization in groups of EGFP-fusion protein expressing cells. Data are from three independent 
experiments.
Experiment BeWo + pEGFP-C3 BeWo + pEGFP-C3- dn-ILK BeWo + pEGFP-C3- wt-ILK BeWo + pEGFP-C3- ca-ILK
1 16/40 13/68 27/47 46/57
2 23/57 8/51 30/47 49/61
3 20/43 15/55 22/36 38/55
Avg. Incidence 
(% of 1.00 +/- SEM)
0.43 +/- 0.02 a0.22 +/- 0.03 b0.62 +/- 0.02 b, c0.77 +/- 0.04
a: Cytoplasmic β-hCG expression markedly decreased in cells expressing dominant negative (dn)-ILK relative to pEGFP-C3 (empty vector) cells (p 
< 0.05)
b: Expression was significantly increased in cells expressing wildtype (wt)- and constitutively active (ca)-ILK compared to cells expressing empty 
vector or dn-ILK (p < 0.05)
c: Cytoplasmic β-hCG expression was significantly increased in cells expressing ca-ILK compared to cells expressing wt-ILK (p < 0.05)Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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cells may involve Snail, a sensitive transcriptional repres-
sor of E-cadherin expression. Tan et al [29] have previ-
ously demonstrated that over-expression of ILK in human
colon carcinoma cell lines stimulated Snail expression.
Recently, these results were extended in Scp2 mouse
mammary epithelial cells where ILK over-expression
resulted in stimulation of Snail expression and loss of E-
cadherin expression [52]. Alternatively, depletion of ILK,
Akt, or Snail resulted in upregulation of E-cadherin
expression. The authors also identified Poly (ADP-ribose)
polymerase-1 (PARP-1) as a component of the signaling
pathway upstream of Snail leading to downregulation of
E-cadherin expression [52]. Our results clearly establish a
correlation of increased ILK activity and alterations in ILK
expression, including nuclear localization of ILK, during
BeWo syncytialization with increased Snail expression in
these cells during this process. With reports of Snail
involved in promoting epithelial-mesenchymal transition
Immunocytochemical analysis of β-human chorionic gonadotropin (β-hCG) expression in BeWo cells transiently transfected  with pEGFP-C3 vector (EGFP), pEGFP-C3 containing dominant negative ILK (EGFP-dn ILK), wildtype ILK (EGFP-wt ILK) or  constitutively active ILK (EGFP-ca ILK) and cultivated under syncytialization conditions for 48 h Figure 6
Immunocytochemical analysis of β-human chorionic gonadotropin (β-hCG) expression in BeWo cells tran-
siently transfected with pEGFP-C3 vector (EGFP), pEGFP-C3 containing dominant negative ILK (EGFP-dn 
ILK), wildtype ILK (EGFP-wt ILK) or constitutively active ILK (EGFP-ca ILK) and cultivated under syncytializa-
tion conditions for 48 h. Rb IgG = rabbit IgG negative control. Scale bar = 25 μm. Data are representative of three inde-
pendent experiments.Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
Page 12 of 14
(page number not for citation purposes)
by downregulating E-cadherin expression through an ILK-
Akt-Snail pathway [29,52], our study also implicates this
pathway in facilitating syncytialization of BeWo trophob-
last cells. Identification of additional members of this ILK
signaling pathway and the specific interactions and
role(s) of all these proteins in trophoblast syncytialization
is ongoing.
Impaired trophoblast fusion and differentiation appears
to be directly associated with pathological conditions
such as preeclampsia or fetal growth restriction [14].
Using DNA microarray analysis, Kudo et al [35] reported
that genes involved in cell and tissue structural dynamics
appeared to be very important for syncytialization. Given
the role of ILK in such processes, we appear to have iden-
tified a new protein involved in trophoblast syncytializa-
tion and differentiation for future study. In addition, our
research also raises the possibility of a more general role
for ILK in cell-cell fusion per se as this fusion process has
been suspected in breast cancer cells and demonstrated in
macrophages and myoblasts – and all of which can highly
express ILK [51,53-56].
Conclusion
These findings demonstrate that ILK activity and expres-
sion play a novel role in syncytialization and differentia-
tion of BeWo cells, and implicate ILK in the same process
in villous cytotrophoblasts in vivo.
ILK, pAkt, and Snail protein expression during a timecourse of BeWo syncytialization Figure 7
ILK, pAkt, and Snail protein expression during a timecourse of BeWo syncytialization. A) Representative immuno-
blots from four independent experiments (n = 4) are shown with a representative immunoblot stained for total protein to 
illustrate comparable protein loading of all gel lanes. B) Densitometric analysis of pAkt expression during BeWo cell culture in 
syncytialization conditions demonstrating a significant decrease in pAkt expression by 24 h (p < 0.05) compared to 0, 9, 12 and 
48 h and a rapid increase in pAkt expression by 48 h of culture compared to 0 h (p < 0.05, n = 4). C) Densitometric analysis of 
Snail protein expression during BeWo cell culture in syncytialization conditions demonstrating that Snail expression becomes 
significantly elevated at 24, 36 and 48 h vs 12 h (p < 0.05, n = 4) and at 48 h of culture compared to expression in proliferating 
conditions at 0 h (p < 0.05, n = 4).Reproductive Biology and Endocrinology 2009, 7:51 http://www.rbej.com/content/7/1/51
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